VanderPol Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$430K Sell
400
-3
-0.7% -$2.87K 0.75% 31
2025
Q3
$333K Buy
403
+30
+8% +$22.3K 0.58% 37
2025
Q2
$291K Sell
373
-9
-2% -$6.99K 0.61% 36
2025
Q1
$315K Buy
382
+1
+0.3% +$832 0.67% 31
2024
Q4
$294K Buy
381
+25
+7% +$20.7K 0.64% 35
2024
Q3
$315K Buy
356
+13
+4% +$11.7K 0.7% 30
2024
Q2
$311K Buy
+343
New +$274K 0.94% 29

Other funds holding LLY

VanderPol Investments's LLY Position: Q4 2025 in Review

VanderPol Investments reduced its Eli Lilly (LLY) stake by 0.74% in Q4 2025, selling an estimated $2.87K and leaving 400 shares worth $430K. The position accounts for 0.75% of the portfolio, ranked #31.

VanderPol Investments first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • VanderPol Investments held 400 shares of Eli Lilly worth $430K as of Q4 2025.
  • VanderPol Investments sold 3 Eli Lilly shares in Q4 2025, an estimated $2.87K.
  • Eli Lilly made up 0.75% of VanderPol Investments's portfolio in Q4 2025, its #31 holding.
  • VanderPol Investments first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on VanderPol Investments's 13F filing for Q4 2025, filed 4 Feb 2026.